# The association between dietary inflammatory index and non-alcoholic fatty liver disease: A systematic review and meta-analysis

**Authors:** Jingjing Lin, Mengna Huang, Lina Shen, Jincheng Wang, Jincheng Wang, Jincheng Wang

PMC · DOI: 10.1371/journal.pone.0345297 · 2026-03-20

## TL;DR

This study finds that a pro-inflammatory diet, measured by the Dietary Inflammatory Index, is linked to a higher risk of non-alcoholic fatty liver disease and its progression to fibrosis.

## Contribution

The study provides a meta-analysis confirming a significant association between dietary inflammation and NAFLD progression, identifying sources of heterogeneity.

## Key findings

- High DII is associated with increased NAFLD risk (OR = 1.33).
- DII is linked to progression to fibrosis (OR = 1.36).
- Geographic region and diagnostic criteria caused heterogeneity in results.

## Abstract

The Dietary Inflammatory Index (DII) is a literature-based tool designed to predict inflammation. Previous studies suggest a potential association between the DII and non-alcoholic fatty liver disease (NAFLD). However, the relationship between the DII and both the incidence and progression of NAFLD remains unclear.

Systematic literature searches were conducted in PubMed, Web of Science, Embase, Scopus, and the Cochrane Library up to July 2025. A random-effects model was applied, and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Sensitivity and subgroup analyses were performed to explore the sources of heterogeneity, while Egger’s test was used to assess publication bias. Review Manager 5.4 and STATA 15.0 were employed for statistical analysis.

Eighteen studies involving 262,468 participants were included. The data indicated a significant association between the DII and NAFLD (OR = 1.33, 95% CI: 1.23–1.44; P < 0.00001) and between the DII and fibrosis (OR = 1.36, 95% CI: 1.20–1.54; P < 0.00001). Subgroup analysis identified geographic region and diagnostic criteria as sources of heterogeneity. Egger’s test revealed publication bias for NAFLD.

A high DII was associated with an increased risk of NAFLD and an increased risk of progression to fibrosis.

PROSPERO, identifier CRD42025632168.

## Linked entities

- **Diseases:** non-alcoholic fatty liver disease (MONDO:0013209)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** dietary (MESH:D000740), cardiovascular disease (MESH:D002318), non-alcoholic cirrhosis (MESH:D008104), Frailty (MESH:D000073496), diabetes (MESH:D003920), depression (MESH:D003866), NAFLD (MESH:D065626), type 2 diabetes (MESH:D003924), obesity (MESH:D009765), ACADEMIC EDITOR (MESH:D007859), end-stage liver disease (MESH:D058625), NASH (MESH:D005235), liver disorder (MESH:D017093), metabolic syndrome (MESH:D024821), MASLD (MESH:D008107), hypertension (MESH:D006973), Dietary Inflammatory (MESH:D007249), Fatty Livers (MESH:D005234), liver fibrosis (MESH:D008103), metabolic disorders (MESH:D008659), functional (MESH:D003291), Fibrosis (MESH:D005355), cancer (MESH:D009369)
- **Chemicals:** triglycerides (MESH:D014280), PONE-D-25-65585R1 (-), fatty acids (MESH:D005227), carbohydrate (MESH:D002241), homocysteine (MESH:D006710), palm oil (MESH:D000073878), free fatty acid (MESH:D005230), polyunsaturated fatty acids (MESH:D005231), fructose (MESH:D005632), olive oil (MESH:D000069463)
- **Species:** Homo sapiens (human, species) [taxon 9606], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Glycine max (soybean, species) [taxon 3847], gut metagenome (species) [taxon 749906]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13004392/full.md

---
Source: https://tomesphere.com/paper/PMC13004392